Related Experiment Video
Updated: Feb 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
The Scorpion Peptide Derivative HP-H1K8 is a Promising Topical Agent Against Methicillin-Resistant Staphylococcus
Xuhua Yang1, Jingyu Yang1, Zhijian Cao2
1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan, 430068, China.
None:
The increasing incidence of antibiotic-resistant Staphylococcus aureus infections has created a critical need for alternative therapeutic agents that are effective and safe. Antimicrobial peptides are considered attractive candidates in this context. A scorpion peptide derivative, designated HP-H1K8, was designed in this study and was then found to possess potent activity against methicillin-resistant S. aureus (MRSA), coupled with low toxicity and high serum stability. The mechanism of action was identified as bacterial membrane disruption. In a mouse model of MRSA-induced skin infection, the topical application of HP-H1K8 was shown to significantly reduce bacterial load in the wound and enhance the healing process. Additionally, the peptide was not prone to inducing bacterial resistance. It is concluded that HP-H1K8 represents a potent topical agent for the treatment of skin infections caused by drug-resistant S. aureus.
More Related Videos
Related Concept Videos
Peptide Bonds
Resistivity
Resistance
Subviral Agents
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...

